Global Cancer Vaccine Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • receipt Report ID : 137098
  • calendar_today Published On: Jan, 2019
  • file_copy Pages: 134
  • list Pharmaceuticals and Healthcare

Cancer vaccines are biological response modifiers. These vaccines work by stimulating or restoring the immune system’s ability to fight against infections and diseases. It is used either as stand-alone therapies or in combination with traditional cancer therapeutics such as chemotherapy and surgery. As cancer is often associated with high mortality rate and are resistant to traditional treatments like chemotherapy and radiation, this has led to the research and development of anti-cancer immunotherapies. The side effects of cancer vaccines may differ from person to person. The most commonly reported are inflation at the site of injection, fever, chills, nausea, blood pressure, and among others.

Scope of the Report:

This report focuses on the Cancer Vaccine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The worldwide market for Cancer Vaccine is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new study.

Market Segment by Manufacturers, this report covers

Dendreon Corporation

NeoStem Oncology

ImmunoGen

Inovio Pharmaceuticals

Novartis

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Preventive vaccines

Therapeutic vaccines

Market Segment by Applications, can be divided into

Prostate Cancer

Cervical Cancer

Others

There are 15 Chapters to deeply display the global Cancer Vaccine market.

Chapter 1, to describe Cancer Vaccine Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Cancer Vaccine, with sales, revenue, and price of Cancer Vaccine, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Cancer Vaccine, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Cancer Vaccine market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Cancer Vaccine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Cancer Vaccine Introduction

1.2 Market Analysis by Type

1.2.1 Preventive vaccines

1.2.2 Therapeutic vaccines

1.3 Market Analysis by Applications

1.3.1 Prostate Cancer

1.3.2 Cervical Cancer

1.3.3 Others

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Dendreon Corporation

2.1.1 Business Overview

2.1.2 Cancer Vaccine Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Dendreon Corporation Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 NeoStem Oncology

2.2.1 Business Overview

2.2.2 Cancer Vaccine Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 NeoStem Oncology Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 ImmunoGen

2.3.1 Business Overview

2.3.2 Cancer Vaccine Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 ImmunoGen Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Inovio Pharmaceuticals

2.4.1 Business Overview

2.4.2 Cancer Vaccine Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Inovio Pharmaceuticals Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Novartis

2.5.1 Business Overview

2.5.2 Cancer Vaccine Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Novartis Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Cancer Vaccine Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Cancer Vaccine Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Cancer Vaccine Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Cancer Vaccine Manufacturer Market Share in 2017

3.3.2 Top 6 Cancer Vaccine Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Cancer Vaccine Market Analysis by Regions

4.1 Global Cancer Vaccine Sales, Revenue and Market Share by Regions

4.1.1 Global Cancer Vaccine Sales and Market Share by Regions (2013-2018)

4.1.2 Global Cancer Vaccine Revenue and Market Share by Regions (2013-2018)

4.2 North America Cancer Vaccine Sales and Growth Rate (2013-2018)

4.3 Europe Cancer Vaccine Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Cancer Vaccine Sales and Growth Rate (2013-2018)

4.5 South America Cancer Vaccine Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Cancer Vaccine Sales and Growth Rate (2013-2018)

5 North America Cancer Vaccine by Countries

5.1 North America Cancer Vaccine Sales, Revenue and Market Share by Countries

5.1.1 North America Cancer Vaccine Sales and Market Share by Countries (2013-2018)

5.1.2 North America Cancer Vaccine Revenue and Market Share by Countries (2013-2018)

5.2 United States Cancer Vaccine Sales and Growth Rate (2013-2018)

5.3 Canada Cancer Vaccine Sales and Growth Rate (2013-2018)

5.4 Mexico Cancer Vaccine Sales and Growth Rate (2013-2018)

6 Europe Cancer Vaccine by Countries

6.1 Europe Cancer Vaccine Sales, Revenue and Market Share by Countries

6.1.1 Europe Cancer Vaccine Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Cancer Vaccine Revenue and Market Share by Countries (2013-2018)

6.2 Germany Cancer Vaccine Sales and Growth Rate (2013-2018)

6.3 UK Cancer Vaccine Sales and Growth Rate (2013-2018)

6.4 France Cancer Vaccine Sales and Growth Rate (2013-2018)

6.5 Russia Cancer Vaccine Sales and Growth Rate (2013-2018)

6.6 Italy Cancer Vaccine Sales and Growth Rate (2013-2018)

7 Asia-Pacific Cancer Vaccine by Countries

7.1 Asia-Pacific Cancer Vaccine Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Cancer Vaccine Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Cancer Vaccine Revenue and Market Share by Countries (2013-2018)

7.2 China Cancer Vaccine Sales and Growth Rate (2013-2018)

7.3 Japan Cancer Vaccine Sales and Growth Rate (2013-2018)

7.4 Korea Cancer Vaccine Sales and Growth Rate (2013-2018)

7.5 India Cancer Vaccine Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Cancer Vaccine Sales and Growth Rate (2013-2018)

8 South America Cancer Vaccine by Countries

8.1 South America Cancer Vaccine Sales, Revenue and Market Share by Countries

8.1.1 South America Cancer Vaccine Sales and Market Share by Countries (2013-2018)

8.1.2 South America Cancer Vaccine Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Cancer Vaccine Sales and Growth Rate (2013-2018)

8.3 Argentina Cancer Vaccine Sales and Growth Rate (2013-2018)

8.4 Colombia Cancer Vaccine Sales and Growth Rate (2013-2018)

9 Middle East and Africa Cancer Vaccine by Countries

9.1 Middle East and Africa Cancer Vaccine Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Cancer Vaccine Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Cancer Vaccine Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Cancer Vaccine Sales and Growth Rate (2013-2018)

9.3 UAE Cancer Vaccine Sales and Growth Rate (2013-2018)

9.4 Egypt Cancer Vaccine Sales and Growth Rate (2013-2018)

9.5 Nigeria Cancer Vaccine Sales and Growth Rate (2013-2018)

9.6 South Africa Cancer Vaccine Sales and Growth Rate (2013-2018)

10 Global Cancer Vaccine Market Segment by Type

10.1 Global Cancer Vaccine Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Cancer Vaccine Sales and Market Share by Type (2013-2018)

10.1.2 Global Cancer Vaccine Revenue and Market Share by Type (2013-2018)

10.2 Preventive vaccines Sales Growth and Price

10.2.1 Global Preventive vaccines Sales Growth (2013-2018)

10.2.2 Global Preventive vaccines Price (2013-2018)

10.3 Therapeutic vaccines Sales Growth and Price

10.3.1 Global Therapeutic vaccines Sales Growth (2013-2018)

10.3.2 Global Therapeutic vaccines Price (2013-2018)

11 Global Cancer Vaccine Market Segment by Application

11.1 Global Cancer Vaccine Sales Market Share by Application (2013-2018)

11.2 Prostate Cancer Sales Growth (2013-2018)

11.3 Cervical Cancer Sales Growth (2013-2018)

11.4 Others Sales Growth (2013-2018)

12 Cancer Vaccine Market Forecast (2018-2023)

12.1 Global Cancer Vaccine Sales, Revenue and Growth Rate (2018-2023)

12.2 Cancer Vaccine Market Forecast by Regions (2018-2023)

12.2.1 North America Cancer Vaccine Market Forecast (2018-2023)

12.2.2 Europe Cancer Vaccine Market Forecast (2018-2023)

12.2.3 Asia-Pacific Cancer Vaccine Market Forecast (2018-2023)

12.2.4 South America Cancer Vaccine Market Forecast (2018-2023)

12.2.5 Middle East and Africa Cancer Vaccine Market Forecast (2018-2023)

12.3 Cancer Vaccine Market Forecast by Type (2018-2023)

12.3.1 Global Cancer Vaccine Sales Forecast by Type (2018-2023)

12.3.2 Global Cancer Vaccine Market Share Forecast by Type (2018-2023)

12.4 Cancer Vaccine Market Forecast by Application (2018-2023)

12.4.1 Global Cancer Vaccine Sales Forecast by Application (2018-2023)

12.4.2 Global Cancer Vaccine Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Cancer Vaccine Picture

Table Product Specifications of Cancer Vaccine

Figure Global Sales Market Share of Cancer Vaccine by Types in 2017

Table Cancer V

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery